Medical Advocates
HIV Infection/Disease
  Non-Hodgkin Lymphoma Drugs
   
Antiretrovirals
 Doxorubicin
 Rituximab
Miscellaneous Therapies
     
     






 
Non-Hodgkin's Lymphoma Main New/Newsworthy Home Page
Last Update:  February 08, 2012
.Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Antiretrovirals
       

     Journal Papers, Abstracts, and Commentaries  

 
FULL-TEXT PDF ARTICLE
 Early Development of non-Hodgkin Lymphoma Following Initiation of Newer
Class Antiretroviral Therapy Among HIV-infected Patients - Implications for
Immune Reconstitution.
Huhn GD, Badri S, Vibhakar S, et al
AIDS Res Ther. 2010 Dec 14;7(1):44.
 Paper

Highly Active Antiretroviral Therapy is Associated with Improved Survival among Patients with
AIDS-Related Primary Central Nervous System
Diamond C, Taylor TH, Im T
Curr HIV Res. 2006 Jul;4(3):375-8.
 Abstract
 
The changing face of HIV-associated lymphoma: what can we learn about optimal therapy
in the post highly active antiretroviral therapy era?
Clayton A, Mughal T.
Hematol Oncol. 2005 Jun 30;22(3):111-120
 Abstract
 
Pharmacokinetic interaction between chemotherapy for non-Hodgkin's lymphoma and
protease inhibitors in HIV-1-infected patients.
Cruciani M, Gatti G, Vaccher E, et al
 J Antimicrob Chemother. 2005 Feb 22;
 Abstract
 
Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and
pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's
lymphoma.
Toffoli G, Corona G, Cattarossi G. et al
Ann Oncol. 2004 Dec;15(12):1805-1809.
 Abstract
 
Impact of Concomitant Antiblastic Chemotherapy and Highly Active Antiretroviral Therapy
on Human Immunodeficiency Virus (HIV) Viremia and Genotyping in HIV-Infected Patients
with Non-Hodgkin Lymphoma.
Simonelli C, Zanussi S, Cinelli R, et al  
Clin Infect Dis. 2003 Sep 15;37(6):820-7.
 Abstract
 
Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active
antiretroviral therapy.
Gerard L, Galicier L, Boulanger E, et al. 
AIDS 2003 Jan 3;17(1):81-87
 Abstract
 
Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi
sarcoma  or non-Hodgkin lymphoma.
Tam HK, Zhang ZF, Jacobson LP, et al.
Int J Cancer 2002 Apr 20;98(6):916-22
 Abstract
 
 
       
     Conference Reports, Abstracts, and Posters
 
 
POSTER
 Influence of ART on Incidence and Prognosis of HIV-1-associated Non-Hodgkin's Lymphoma:
European Multi-Cohort Study
J Bohlius, M Egger, and Collaboration of Observational HIV Epidemiological Res Europe (COHERE)
Study Group
(16 CROI)
 PDF Poster     Abstract

POSTER
 Decreased Cases of and Improved Survival from AIDS-associated Non-Hodgkin's
Lymphoma in the Era of Highly Active Antiretroviral Therapy
C Diamond, T H Taylor,  H A Culver, et al.
 (11 CROI)
 PDF Poster       Abstract
 
Doxorubicin
       

     Journal Papers, Abstracts, and Commentaries  

 
Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active
antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's
lymphoma.
Xicoy B, Ribera JM, Miralles P, et al 
Haematologica. 2007 Feb;92(2):191-198.
 Abstract

Liposome-Encapsulated Doxorubicin in Combination With Standard Agents
(cyclophosphamide, vincristine, prednisone) in Patients With Newly Diagnosed
AIDS-Related Non-Hodgkin's Lymphoma: Results of Therapy and Correlates of Response.
Levine AM, Tulpule A, Espina B, et al
Clin Oncol. 2004 Jul 1;22(13):2662-70.
 Abstract
Rituximab
       

     Journal Papers, Abstracts, and Commentaries  

 
Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated
non-Hodgkin lymphoma: A pooled analysis of 15 prospective studies.
Castillo JJ, Echenique IA.
Am J Hematol. 2011 Dec 17.
Abstract

Phase II Trial of CHOP Plus Rituximab in Patients With HIV-Associated Non-Hodgkin's
Lymphoma.
Boue F, Gabarre J, Gisselbrecht C, et al
J Clin Oncol. 2006 Aug 8;
Abstract

Rituximab does not improve clinical outcome in a randomized phase III trial of CHOP
with or without rituximab in patients with HIV-associated non-Hodgkin's lymphoma:
AIDS-malignancies consortium trial 010.
Kaplan LD, Lee JY, Ambinder RF, et al 
Blood. 2005 May 24;
 Abstract

Rituximab plus infusional cyclophosphamide, doxorubicin and etoposide (R-CDE) in HIV-
associated non-Hodgkin's lymphoma: pooled results from three phase II trials.
Spina M, Jaeger U, Sparano JA.et al 
Blood. 2004 Nov 18;
Abstract
 
Infusional CDE with rituximab for the treatment of human immunodeficiency virus-
associated non-Hodgkin's lymphoma: preliminary results of a phase I/II study.
Tirelli U, Spina M, Jaeger U, et al.
Recent Results Cancer Res 2002;159:149-53
 Abstract
 
     Conference Reports, Abstracts, and Posters
 
  The safety of Rituximab in HIV non-Hodgkin lymphoma patients with low CD4 cell counts
K. Wheatley, J. Roe, M. Nelso, et al
 (6th IAS Conference)
 Abstract

POSTER
 Treatment of AIDS-related Lymphoma: Rituximab May Be Beneficial Even in Severely
Immunosuppressed Patients
C Wyen, G Faetkenheuer, M Oette, et al
 (15th CROI)
 PDF Poster     Abstract
Miscellaneous Therapies
       
     Journal Papers, Abstracts, and Commentaries  
 
 
Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of
lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin
lymphoma.
Spina M, Chimienti E, Martellotta F, et al
 Cancer. 2010 Jan 27
 Abstract.

Human immunodeficiency virus-associated diffuse non-Hodgkin's lymphoma in Venezuelan
patients: treatment with full-dose cyclophosphamide-doxorubicin-vincristine-prednisone
without routine use of granulocyte-colony stimulating factor.
Hernandez DE, Hernandez AE 
Eur J Cancer Care (Engl). 2006 Dec;15(5):493-6.
 Abstract.

Treatment of AIDS Related Non-Hodgkin's Lymphoma with Combination Mitoguazone
Dihydrochloride and Low Dose Chop Chemotherapy: Results of a Phase II study.
Tulpule A, Espina BM, Pedro Santabarbara AB, et al
Invest New Drugs. 2004 Jan;22(1):63-8
 Abstract.
 

High-Dose Cytosine-Arabinoside and Cisplatin Regimens as Salvage Therapy for
Refractory or Relapsed AIDS-Related Non-Hodgkin's Lymphoma.
Bi J, Espina BM, Tulpule A et al.
 J Acquir Immune Defic Syndr 2001 Dec  15;28(5):416-421
 Abstract
 
Human immunodeficiency virus-related non-Hodgkin lymphoma: activity of infusional
cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40
patients.
Spina M, Vaccher E, Juzbasic S, Milan I, et al.
 Cancer 2001 Jul 1;92(1):200-6
 Abstract
 
     Conference Reports, Abstracts, and Posters
 
  The impact of concomitant antiblastic chemotherapy and HAART on HIV-viraemia and
resistance profile in HIV-infected patients with non-Hodgkin's lymphoma 
C Simonelli, S Zanussi, R.Cinelli, et al.
(1st European HIV Drug Resistance Workshop)
Abstract

Non-Hodgkin's Lymphoma Main New/Newsworthy Home Page

HIV-Related  Non-Hodgkin's Lymphoma Drugs